Tango Therapeutics, Inc.
TNGXNasdaqCIK 1819133HealthcareFiscal year ends Dec 31
Reports and events: 97 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2306:36 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-429423 |
| 2026-08-1121:13 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-344997 |
| 2026-08-1111:20 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-343434 |
| 2026-08-1111:12 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-343424 |
| 2026-08-0710:41 ET | 8-K/A | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-339070 |
| 2026-08-0621:30 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-26-338480 |
| 2026-06-2321:19 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-279788 |
| 2026-06-1021:22 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-26-266078 |
| 2026-06-0811:15 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-260679 |
| 2026-06-0421:19 ET | 8-K | 5.07 Shareholder vote results | 0001193125-26-257760 |
| 2026-05-1320:16 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-221677 |
| 2026-05-1320:15 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-221656 |
| 2026-05-0813:22 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-213491 |
| 2026-04-1711:12 ET | DEF 14A | Proxy statementPeriod 2026-04-16 | 0001193125-26-160287 |
| 2026-04-1513:19 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-156127 |
| 2026-03-0512:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-092535 |
| 2026-03-0512:10 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001193125-26-092518 |
| 2026-02-1021:15 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001193125-26-044719 |
| 2026-01-0814:10 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-007086 |
| 2026-01-0512:09 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-001495 |
| 2025-11-2121:15 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001193125-25-291391 |
| 2025-11-2113:36 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement | 0001193125-25-290679 |
| 2025-11-1421:15 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001193125-25-282980 |
| 2025-11-0414:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-263684 |
| 2025-11-0414:09 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-263680 |
| 2025-10-2410:17 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001193125-25-249302 |
| 2025-10-2311:04 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-247658 |
| 2025-08-2520:06 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-25-187680 |
| 2025-08-0511:10 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000950170-25-102392 |
| 2025-08-0511:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-102387 |
| 2025-06-0620:02 ET | 8-K | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-25-137032 |
| 2025-05-1211:10 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000950170-25-068549 |
| 2025-05-1211:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-068546 |
| 2025-04-2118:29 ET | DEF 14A | Proxy statementPeriod 2025-04-21 | 0000950170-25-056230 |
| 2025-02-2712:12 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000950170-25-028353 |
| 2025-02-2712:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-028345 |
| 2025-01-1312:30 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-004977 |
| 2025-01-0212:07 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000895345-25-000001 |
| 2024-11-0702:35 ET | SC 13D/A | Ownership report, active investor, amended | 0000895345-24-000549 |
| 2024-11-0612:43 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000950170-24-121818 |
| 2024-11-0612:23 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-121810 |
| 2024-10-2813:22 ET | SC 13D/A | Ownership report, active investor, amended | 0000895345-24-000491 |
| 2024-10-1501:40 ET | SC 13D/A | Ownership report, active investor, amended | 0000895345-24-000428 |
| 2024-10-1523:25 ET | SC 13D/A | Ownership report, active investor, amended | 0000895345-24-000424 |
| 2024-09-0400:45 ET | SC 13D/A | Ownership report, active investor, amended | 0001193125-24-213369 |
| 2024-08-0711:13 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0000950170-24-092274 |
| 2024-08-0711:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-092270 |
| 2024-06-0620:06 ET | 8-K | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-24-156048 |
| 2024-05-2311:18 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-145434 |
| 2024-05-0811:21 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0000950170-24-055065 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:06 ET. Listed shows no prices and gives no investment advice.